Found: 6
Select item for more details and to access through your institution.
A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell--tumor cell hybrid vaccines.
- Published in:
- Nature Medicine, 2003, v. 9, n. 9, p. 1215, doi. 10.1038/nm923
- By:
- Publication type:
- Article
Construction and production of oncotropic vectors, derived from MVM(p), that share reduced sequence homology with helper plasmids.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 9, p. 762
- By:
- Publication type:
- Article
Modulation of the metabolism and adverse effects of benzo[a]pyrene by a specific antibody: a novel host factor in environmental carcinogenesis?
- Published in:
- Carcinogenesis, 2005, v. 26, n. 4, p. 835, doi. 10.1093/carcin/bgi010
- By:
- Publication type:
- Article
Generation of cell hybrids via a fusogenic cell line.
- Published in:
- Journal of Gene Medicine, 2006, v. 8, n. 7, p. 919, doi. 10.1002/jgm.906
- By:
- Publication type:
- Article
In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.
- Published in:
- Journal of Gene Medicine, 2005, v. 7, n. 2, p. 189, doi. 10.1002/jgm.653
- By:
- Publication type:
- Article
Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.
- Published in:
- Journal of Gene Medicine, 2004, v. 6, p. S203, doi. 10.1002/jgm.504
- By:
- Publication type:
- Article